ONCOPEPTIDES AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.22 SEK | -3.59% |
|
+9.34% | -57.96% |
| Apr. 15 | Oncopeptides AB Secures National Reimbursement for Pepaxti in Spain | CI |
| Apr. 04 | Oncopeptides AB Provides Sales Guidance for the First Quarter of 2024 | CI |
Quotes 5-day view
Delayed Quote Nasdaq Stockholm| 2024-05-07 | 2024-05-08 | 2024-05-10 | 2024-05-13 | |
|---|---|---|---|---|
| Last | 2.975 kr | 2.905 kr | 3.34 kr | 3.22 kr |
| Volume | 990 908 | 647 684 | 1 451 778 | 1 509 934 |
| Change | +1.02% | -2.35% | +14.97% | -3.59% |
| Opening | 3.01 | 2.98 | 2.91 | 3.34 |
| High | 3.02 | 3.11 | 3.37 | 3.36 |
| Low | 2.75 | 2.88 | 2.85 | 3.04 |
Performance
| 1 day | -3.59% | ||
| 1 week | +9.34% | ||
| Current month | +10.65% | ||
| 1 month | -35.08% | ||
| 3 months | -53.32% | ||
| 6 months | -51.21% | ||
| Current year | -57.96% | ||
| 1 year | -60.53% | ||
| 3 years | -97.30% | ||
| 5 years | -97.33% |
Volumes
marketsDaily volume
1 509 934
Estimated daily volume
1 509 934
Avg. Volume 20 sessions
1 365 102
Daily volume ratio
1.11
Avg. Volume 20 sessions SEK
4 395 628.44
Avg. Volume 20 sessions USD
405 676.94
Record volume 1
72 950 460
Record volume 2
70 164 860
Record volume 3
50 384 050
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (SEK)
732 510 657
Capitalization (USD)
67 604 141
Net sales (SEK)
35 200 000
Net sales (USD)
3 248 643
Number of employees
57
Sales / Employee (SEK)
617 544
Sales / Employee (USD)
56 994
Free-Float
95.37 %
Free-Float capitalization (SEK)
672 065 064
Free-Float capitalization (USD)
62 025 557
Average Daily Capital Traded
0.6%
Highs and lows
1 week
2.85
3.37
1 month
2.755.48
Current year
2.758.30
1 year
2.7510.60
3 years
2.75127.70
5 years
2.75215.00
10 years
2.75215.00
Indicators
Moving average 5 days
3.03
Moving average 20 days
3.42
Moving average 50 days
3.69
Moving average 100 days
4.37
Price spread / (MMA5)
-5.93%
Price spread / (MMA20)
+6.34%
Price spread / (MMA50)
+14.46%
Price spread / (MMA100)
+35.85%
STIM
RSI 9 days
35.26
RSI 14 days
38.84
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -3.59% | +9.34% | -57.96% | -60.53% | 67.6M | ||
| +1.69% | +6.81% | +5.66% | +23.75% | 109B | ||
| +0.32% | +1.91% | +11.23% | +31.25% | 105B | ||
| -1.64% | -5.83% | -0.38% | -7.56% | 22.25B | ||
| +1.15% | -0.67% | -12.15% | -11.90% | 22.09B | ||
| -0.65% | -0.70% | -7.66% | -30.64% | 18.68B | ||
| +2.99% | +0.90% | -36.52% | -30.25% | 17.58B | ||
| +0.65% | -0.19% | -10.09% | -31.97% | 16.85B | ||
| -0.40% | -3.92% | +3.33% | +40.78% | 13.76B | ||
| -0.09% | -2.47% | +36.58% | +9.57% | 12.46B | ||
| -1.75% | -7.49% | +288.77% | +221.13% | 8.12B | ||
| -0.62% | -5.06% | -28.59% | -38.84% | 7.87B | ||
| -3.55% | -4.85% | -52.23% | -69.29% | 7.81B | ||
| -0.31% | -1.08% | -0.80% | +31.73% | 7.69B | ||
| -1.08% | -1.48% | +4.82% | +38.39% | 7.62B | ||
| +0.78% | -1.05% | +4.62% | +32.78% | 7.09B | ||
| Average | -0.38% | +0.28% | +9.29% | +9.27% | ||
| Weighted average by Cap. | +0.52% | +1.57% | +7.39% | +16.13% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
c4f7126.5udzbXWBaBoivs8H5mPc7zyHX1_zdVggxw7jfHzItyQ.h99FC0T4RVF61PpY3lKXt1q0NRawHg8TtkOPFAaw1nzfjTVaPOsGU3D3qA
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 11:29:58 am | 3.22 | 20,000 | 1,490,912 |
| 11:29:58 am | 3.22 | 3,500 | 1,470,912 |
| 11:29:58 am | 3.22 | 4,586 | 1,467,412 |
| 11:29:58 am | 3.22 | 4 | 1,462,826 |
| 11:29:58 am | 3.22 | 1,165 | 1,462,822 |
| 11:29:58 am | 3.22 | 6,717 | 1,461,657 |
| 11:29:58 am | 3.22 | 1,480 | 1,454,940 |
| 11:23:36 am | 3.225 | 22 | 1,453,460 |
| 11:23:36 am | 3.225 | 155 | 1,453,438 |
| 11:22:37 am | 3.225 | 33 | 1,453,283 |
Monthly variations
Annual change
| 2024 | -57.96% | ||
| 2023 | -36.95% | ||
| 2022 | +44.64% | ||
| 2021 | -95.05% | ||
| 2020 | +33.73% | ||
| 2019 | -3.42% | ||
| 2018 | +64.25% | ||
| 2017 | +86.05% |
- Stock Market
- Equities
- ONCO Stock
- Quotes Oncopeptides AB